Patrik Hildingsson: No Link Between Snus, Nicotine Pouches and Oral or Lip Cancer
“Patrik Hildingsson: 7 Recent Scientific Studies Confirm No Link Between Snus, Nicotine Pouches and Oral or Lip Cancer”
Patrik Hildingsson, Director Oral Category Communications at PMI, revealed that extensive scientific research and clinical trials have been conducted to examine any potential link between the use of snus and nicotine pouches (ZYN) and the risk of oral or lip cancer. He confirmed that the findings show no direct association between these products and the occurrence of cancer.
In response to a question from Aswaq News, Hildingsson explained that Swedish Match submitted approximately 360 scientific studies and three clinical trials to the U.S. Food and Drug Administration (FDA), which has authorized the marketing of eight snus products as modified-risk tobacco products after thoroughly reviewing the research.
He noted that among these, there were eight specialized studies specifically focused on the relationship between snus, nicotine pouch (ZYN) use, and oral cancer. Seven of these studies found no connection, while only one study suggested a possible association.
Hildingsson added that scientific research has shown that the risks of heart cancer, strokes, and lung diseases due to traditional cigarette smoking are significantly higher than those associated with the exclusive use of snus and nicotine pouches (ZYN). He emphasized that the main source of harm in smoking comes from the combustion process caused by lighting a cigarette, something that does not occur with oral smokeless products, which are placed under the lip without burning.
Regarding market trends, Hildingsson confirmed that there is a growing interest among adult smokers in Sweden to reduce the harm caused by smoking. Snus and nicotine pouches have been widely used there for over 200 years, driven by cultural factors and aligning with the Swedish government’s strategy to minimize health risks related to smoking.
He concluded by noting that Sweden currently imports nicotine from Brazil and four other countries, due to the country’s limited local capacity to cultivate enough tobacco to meet industrial
demand